Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo … [et.al]
Tipo de material:
TextoIdioma: Español Detalles de publicación: Bogotá, D. C; Instituto Nacional de Salud; 2007Descripción: 159-71; ilus.;tblsTema(s): Resumen: Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S
No hay ítems correspondientes a este registro
Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S
No hay comentarios en este titulo.
Ingresar a su cuenta para colocar un comentario.